HER2+ Cancer
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901 (NCT01526473) | H. Kim Lyerly | 2012-02-01 |
Track HER2+ Cancer automatically
Every clearance here is in the API, with alerts when new ones post.